ABBV vs PSTV · P/E 81, rev $16.99B vs P/E 0.2, rev $5.8M
AbbVie Inc (ABBV) versus Plus Therapeutics Inc (PSTV) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
Plus Therapeutics Inc (PSTV) is a biotechnology company listed on NASDAQ.
Latest reported ABBV revenue for 2026-06-30 was $16.99B. Net income was $3.61B. Revenue was up 13.3% from 2026-03-31 to 2026-06-30. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported PSTV revenue for 2024-12-31 was $5.8M. Net income was -$13.0M. Revenue was up 18.5% from 2023-12-31 to 2024-12-31. PSTV currently screens at market cap $29.7M and trailing P/E 0.2.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. PSTV currently screens at market cap $29.7M and trailing P/E 0.2.
Not investment advice. Open the ABBV and PSTV stock pages for the full models.
Not investment advice.